Evidence map›Paper›PMID 34562865›Full record

ReviewDiabetes & metabolic syndrome

Diabetes Mellitus and COVID-19: Review Article.

Mahmoud Nassar, Ahmed Daoud, Nso Nso, Luis Medina, Victoria Ghernautan, Harangad Bhangoo, Andrew Nyein, Mahmoud Mohamed, Ahmed Alqassieh, Karim Soliman and 3 more

Abstract readReview
In one paragraph

Review in Diabetes & metabolic syndrome. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mahmoud NassarDepartment of Medicine, Icahn School of Medicine at Mount Sinai / NYC Health + Hospitals/Queens, New York, USA. Electronic address: dr.nassar@aucegypt.edu.
Ahmed DaoudInternal Medicine Department, Faculty of Medicine Cairo University, Cairo, Egypt. Electronic address: Ahmed.daoud84@yahoo.com.
Nso NsoDepartment of Medicine, Icahn School of Medicine at Mount Sinai / NYC Health + Hospitals/Queens, New York, USA. Electronic address: mcviali@yahoo.co.uk.
Luis MedinaDepartment of Medicine, Icahn School of Medicine at Mount Sinai / NYC Health + Hospitals/Queens, New York, USA. Electronic address: Dr.luismedi@gmail.com.
Victoria GhernautanDepartment of Medicine, Icahn School of Medicine at Mount Sinai / NYC Health + Hospitals/Queens, New York, USA. Electronic address: ghernauv@nychhc.org.
Harangad BhangooDepartment of Medicine, Icahn School of Medicine at Mount Sinai / NYC Health + Hospitals/Queens, New York, USA. Electronic address: harangadbhangoo@gmail.com.
Andrew NyeinNew York Institute of Technology College of Osteopathic Medicine, NYC, USA. Electronic address: Anyein@nyit.edu.
Mahmoud MohamedMedicine department, North Mississippi Medical Center, Tupelo, MS, USA. Electronic address: Mmohame3@uthsc.edu.
Ahmed AlqassiehDepartment of Surgery, Medical University of South Carolina, Charleston, SC, USA. Electronic address: alqassie@musc.edu.
Karim SolimanDivision of Nephrology, Department of Medicine and Surgery, Medical University of South Carolina, Charleston, SC, USA. Electronic address: drkarimsoliman@gmail.com.
Mostafa AlfishawyInfectious Diseases Consultants and Academic Researchers of Egypt IDCARE, Egypt. Electronic address: malfishawy@kasralainy.edu.eg.
Issac SachmechiChair of Division of Endocrinology, Department of Medicine, Icahn School of Medicine at Mount Sinai / NYC Health + Hospitals/Queens USA. Electronic address: SACHMECI@nychhc.org.
Anoop MisraChairman, Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, Chairman, National Diabetes, Obesity, And Cholesterol Foundation (N-DOC), President, Diabetes Foundation (India) (DFI), USA. Electronic address: anoopmisra@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsWe aim to cover most of the current evidence on the mutual effect of diabetes & COVID-19 infection on each other and the management of the COVID-19 patients with diabetes.

methodsWe utilized databases to review the current evidence related to diabetes mellitus and COVID-19.

resultsWe discussed the most recent evidence of diabetes milieus and COVID-19 regarding risk factors, management, complications, and telemedicine.

conclusionDiabetes mellitus is associated with a significant risk of complications, extended hospital stays, and mortality in COVID-19 infected patients.

Indexed as

TelemedicineBlood GlucoseCOVID-19Diabetes MellitusHumansHypoglycemic AgentsRisk FactorsSARS-CoV-2Blood GlucoseHypoglycemic AgentsCOVID-19Diabetes mellitusManagementPathophysiologyRisk factorTyp 2Type 1

Identifiers

PMID34562865
PMCPMC8416292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.